206 related articles for article (PubMed ID: 23116461)
21. Melanocortin 1 Receptor Targeted Imaging of Melanoma With Gold Nanocages and Positron Emission Tomography.
Zhao Y; Pang B; Detering L; Luehmann H; Yang M; Black K; Sultan D; Xia Y; Liu Y
Mol Imaging; 2018; 17():1536012118775827. PubMed ID: 29873290
[TBL] [Abstract][Full Text] [Related]
22. NDP-MSH binding melanocortin-1 receptor ameliorates neuroinflammation and BBB disruption through CREB/Nr4a1/NF-κB pathway after intracerebral hemorrhage in mice.
Wu X; Fu S; Liu Y; Luo H; Li F; Wang Y; Gao M; Cheng Y; Xie Z
J Neuroinflammation; 2019 Oct; 16(1):192. PubMed ID: 31660977
[TBL] [Abstract][Full Text] [Related]
23. DOTA alpha-melanocyte-stimulating hormone analogues for imaging metastatic melanoma lesions.
Froidevaux S; Calame-Christe M; Sumanovski L; Tanner H; Eberle AN
Ann N Y Acad Sci; 2003 Jun; 994():378-83. PubMed ID: 12851339
[TBL] [Abstract][Full Text] [Related]
24. Melanocortin 1 receptor regulates melanoma cell migration by controlling syndecan-2 expression.
Chung H; Lee JH; Jeong D; Han IO; Oh ES
J Biol Chem; 2012 Jun; 287(23):19326-35. PubMed ID: 22493442
[TBL] [Abstract][Full Text] [Related]
25. Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy.
López MN; Pereda C; Ramírez M; Mendoza-Naranjo A; Serrano A; Ferreira A; Poblete R; Kalergis AM; Kiessling R; Salazar-Onfray F
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1219-27. PubMed ID: 17325166
[TBL] [Abstract][Full Text] [Related]
26. Melanocortin-1 receptor-targeting with radiolabeled cyclic α-melanocyte-stimulating hormone analogs for melanoma imaging.
Raposinho PD; Correia JD; Oliveira MC; Santos I
Biopolymers; 2010; 94(6):820-9. PubMed ID: 20564045
[TBL] [Abstract][Full Text] [Related]
27. The melanocortin-1 receptor reversely regulates the melanin synthesis and migration of melanoma cells via dimerization-induced conformational changes.
Park J; Jeong D; Jang B; Oh ES
Biochem Biophys Res Commun; 2019 Oct; 518(4):739-745. PubMed ID: 31472961
[TBL] [Abstract][Full Text] [Related]
28. Glycosylated DOTA-alpha-melanocyte-stimulating hormone analogues for melanoma targeting: influence of the site of glycosylation on in vivo biodistribution.
Bapst JP; Calame M; Tanner H; Eberle AN
Bioconjug Chem; 2009 May; 20(5):984-93. PubMed ID: 19388674
[TBL] [Abstract][Full Text] [Related]
29. Activation of the Melanocortin-1 Receptor by NDP-MSH Attenuates Oxidative Stress and Neuronal Apoptosis through PI3K/Akt/Nrf2 Pathway after Intracerebral Hemorrhage in Mice.
Fu S; Luo X; Wu X; Zhang T; Gu L; Wang Y; Gao M; Cheng Y; Xie Z
Oxid Med Cell Longev; 2020; 2020():8864100. PubMed ID: 33274009
[TBL] [Abstract][Full Text] [Related]
30. A (99m)Tc(CO)(3)-labeled pyrazolyl-alpha-melanocyte-stimulating hormone analog conjugate for melanoma targeting.
Raposinho PD; Correia JD; Alves S; Botelho MF; Santos AC; Santos I
Nucl Med Biol; 2008 Jan; 35(1):91-9. PubMed ID: 18158948
[TBL] [Abstract][Full Text] [Related]
31. Development of melanoma-targeted polymer micelles by conjugation of a melanocortin 1 receptor (MC1R) specific ligand.
Barkey NM; Tafreshi NK; Josan JS; De Silva CR; Sill KN; Hruby VJ; Gillies RJ; Morse DL; Vagner J
J Med Chem; 2011 Dec; 54(23):8078-84. PubMed ID: 22011200
[TBL] [Abstract][Full Text] [Related]
32. Multiple Applications of a Novel Biarsenical Imaging Probe in Fluorescence and PET Imaging of Melanoma.
Kondrashov M; Svensson SPS; Ström P; Westermark A; Jacobson-Ingemyr H; Takano A; Tari L; Tóth M; Cai M; Hruby VJ; Schou M
Bioconjug Chem; 2021 Mar; 32(3):497-501. PubMed ID: 33576604
[TBL] [Abstract][Full Text] [Related]
33. Melanoma targeting with alpha-melanocyte stimulating hormone analogs labeled with fac-[99mTc(CO)3]+: effect of cyclization on tumor-seeking properties.
Raposinho PD; Xavier C; Correia JD; Falcão S; Gomes P; Santos I
J Biol Inorg Chem; 2008 Mar; 13(3):449-59. PubMed ID: 18183429
[TBL] [Abstract][Full Text] [Related]
34. Preclinical Melanoma Imaging with
Zhang C; Zhang Z; Lin KS; Pan J; Dude I; Hundal-Jabal N; Colpo N; Bénard F
Theranostics; 2017; 7(4):805-813. PubMed ID: 28382155
[TBL] [Abstract][Full Text] [Related]
35. Technetium-99m-labeled Arg-Gly-Asp-conjugated alpha-melanocyte stimulating hormone hybrid peptides for human melanoma imaging.
Yang J; Guo H; Miao Y
Nucl Med Biol; 2010 Nov; 37(8):873-83. PubMed ID: 21055617
[TBL] [Abstract][Full Text] [Related]
36. A retro-inverso α-melanocyte stimulating hormone analog with MC1R-binding selectivity.
Weeden T; Stefano J; Duan S; Edling A; Hou L; Chuang WL; Perricone MA; Pan C; Dzuris JL
J Pept Sci; 2011 Jan; 17(1):47-55. PubMed ID: 21171144
[TBL] [Abstract][Full Text] [Related]
37.
Yang J; Xu J; Gonzalez R; Lindner T; Kratochwil C; Miao Y
Sci Transl Med; 2018 Nov; 10(466):. PubMed ID: 30404861
[TBL] [Abstract][Full Text] [Related]
38. Design, Synthesis, In Vitro and In Vivo Evaluation of Heterobivalent SiFA
Cheng X; Hübner R; von Kiedrowski V; Fricker G; Schirrmacher R; Wängler C; Wängler B
Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34200477
[TBL] [Abstract][Full Text] [Related]
39. Novel [
Qiao Z; Xu J; Gonzalez R; Miao Y
Mol Pharm; 2020 Sep; 17(9):3581-3588. PubMed ID: 32663011
[TBL] [Abstract][Full Text] [Related]
40. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
